Armistice Capital, Llc Avalo Therapeutics, Inc. (AVTX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $513 Million. The most recent transaction as insider was on May 18, 2021, when has been sold 22,000 shares (Common Stock) at a price of $2.33 per share, resulting in proceeds of $51,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1M

0% 3M change

0% 12M change

Total Value Held $513 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 18 2021	BUY Open market or private purchase	$51,260 $2.33 p/Share	22,000 Added 0.06%	39,100,000 Common Stock
May 17 2021	BUY Open market or private purchase	$66,000 $2.2 p/Share	30,000 Added 0.08%	39,078,000 Common Stock
May 14 2021	BUY Open market or private purchase	$275,200 $2.15 p/Share	128,000 Added 0.33%	39,048,000 Common Stock
Apr 15 2021	BUY Conversion of derivative security	$12,571,430 $2.0 p/Share	6,285,715 Added 13.9%	38,920,000 Common Stock
Jan 08 2021	BUY Open market or private purchase	$6,500,000 $2.6 p/Share	2,500,000 Added 7.12%	32,634,285 Common Stock
Dec 03 2020	BUY Open market or private purchase	$48,800 $2.44 p/Share	20,000 Added 0.07%	30,134,285 Common Stock
Nov 25 2020	BUY Open market or private purchase	$35,850 $2.39 p/Share	15,000 Added 0.05%	30,114,285 Common Stock
Nov 24 2020	BUY Open market or private purchase	$114,559 $2.4 p/Share	47,733 Added 0.16%	30,099,285 Common Stock
Nov 23 2020	BUY Open market or private purchase	$86,459 $2.32 p/Share	37,267 Added 0.12%	30,051,552 Common Stock
Sep 04 2020	BUY Open market or private purchase	$220,000 $2.2 p/Share	100,000 Added 0.33%	30,014,285 Common Stock
Jun 09 2020	BUY Open market or private purchase	$4,384,200 $2.5 p/Share	1,753,680 Added 5.54%	29,914,285 Common Stock
Mar 17 2020	BUY Open market or private purchase	$3,999,999 $2.05 p/Share	1,951,219 Added 6.48%	28,160,605 Common Stock
Mar 16 2020	SELL Other acquisition or disposition	-	3,455,129 Reduced 11.65%	26,209,386 Common Stock
Feb 03 2020	BUY Open market or private purchase	$3,905,502 $3.98 p/Share	981,282 Added 3.2%	29,664,515 Common Stock
Jan 24 2020	BUY Conversion of derivative security	-	3,000,000 Added 9.47%	28,683,233 Common Stock
Jan 22 2020	BUY Conversion of derivative security	-	5,000,000 Added 16.3%	25,683,233 Common Stock
Sep 06 2019	BUY Open market or private purchase	$2,950,000 $2.95 p/Share	1,000,000 Added 4.61%	20,683,233 Common Stock
Sep 04 2019	BUY Open market or private purchase	$3,756,000 $3.13 p/Share	1,200,000 Added 5.75%	19,683,233 Common Stock
Aug 30 2019	BUY Open market or private purchase	$79,429 $3.23 p/Share	24,591 Added 0.13%	18,483,233 Common Stock
Aug 29 2019	BUY Open market or private purchase	$55,125 $3.21 p/Share	17,173 Added 0.09%	18,458,642 Common Stock
Aug 19 2019	BUY Open market or private purchase	$8,204 $3.57 p/Share	2,298 Added 0.01%	18,441,469 Common Stock
Aug 16 2019	BUY Open market or private purchase	$33,909 $3.43 p/Share	9,886 Added 0.05%	18,439,171 Common Stock
Aug 14 2019	BUY Open market or private purchase	$191,558 $3.37 p/Share	56,842 Added 12.44%	400,000 Common Stock
Jun 05 2019	BUY Open market or private purchase	$24,850 $4.97 p/Share	5,000 Added 0.03%	18,429,285 Common Stock
Jun 03 2019	BUY Open market or private purchase	$47,300 $4.73 p/Share	10,000 Added 0.05%	18,424,285 Common Stock

Also insider at

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL